Hands-on Courses
|
實作課程 |
||||
|
林口長庚醫院 研究大樓 |
||||
|
Time |
Venue |
Topic |
Speaker |
|
|
10:00-12:00 |
1F會議室1 |
Fusion biopsy規劃與實作 |
(限20名) |
邵翊紘 |
|
1F會議室2 |
HIFU規劃與實作 |
(限20名) |
虞凱傑 |
|
|
林口長庚醫院 質子大樓 |
||||
|
Time |
Venue |
Topic |
Speaker |
|
|
10:00-12:00 |
2F 第三簡報室 |
RIRS結石模型實作 |
(限12名) |
林國仁 |
|
2F 討論室 |
Transplantation豬腎血管實作 |
(限16名) |
王叙涵 |
|
|
高階實作課程 |
||||
|
林口長庚醫院 研究大樓 |
||||
|
Time |
Venue |
Topic |
Speaker |
|
|
08:30-16:30 |
8F 外科手術訓練中心 |
HUGO URO masterclass |
(限6名) |
Rocco Papalia
|
|
14:00-17:00 |
8F 外科手術訓練中心 手術訓練區 1 |
Da Vinci robotic hands-on course |
(限45名) |
王百孚 |
Live Demonstration
|
Lunch Symposium |
|||
|
Time |
Topic |
Speaker |
Moderator |
|
12:00-12:30 |
Paving the pathway to bladder outlet through UroLift's anterior channel: Techniques, tips and troubleshooting |
洪健華 |
廖俊厚 |
|
12:30-13:00 |
Hugo robotic surgical system: What to expect |
Rocco Papalia |
歐宴泉 |
|
2024 highlights in GU Treatment-Part 1 |
|||
|
Time |
Topic |
Speaker |
Moderator |
|
13:00-13:15 |
Opening |
陳建宗、馮思中、吳俊德 |
|
|
13:15-13:35 |
Voiding dysfunction in pediatric urology |
楊緒棣 |
林嘉祥 |
|
13:35-13:55 |
Bending the learning curve for rare diseases in urology: An argument for collaboration in bladder exstrophy |
Aseem Shukla |
黃一勝 |
|
13:55-14:15 |
HIFU: The surgical scalpel of focal therapy |
Arvin George |
吳俊德 |
|
14:15-14:35 |
Epigenetic impact of truncal mutations in clear cell renal cell carcinoma |
Teh Bin Tean |
馮思中 |
|
14:35-14:55 |
Reconstructive urologic robotic surgery in pediatric and adult patients |
Sang Hoon Song |
查岱龍 |
|
14:55-15:15 |
Discussion |
All |
|
|
15:15-15:30 |
Break |
||
|
Live Demo：MIST |
|||
|
15:30-17:00 |
林口霧都論劍：攝護腺肥大新世代微創手術 MIST (Minimal Invasive Surgical Treatment): The Next Generation BPH Surgeries Moderator：陳建綸 Panelist：陳 煜、闕士傑、黃志賢、崔克宏、阮雍順、黃冠華 王弘仁、吳政哲、歐建慧、陳欣宏、李建儀、蔡維恭 |
||
|
Category |
RWT |
WVTT |
PUL |
|
Procedure |
AquaBlation |
Rezúm |
UroLift |
|
Case Briefing |
林晏頎 |
李宗霖 |
鄧子麒 |
|
Surgeon |
TEOH Yuen Chun Jeremy |
蔡翰宇 |
闕士傑 |
|
2024 highlights in GU Treatment-Part 2 |
|||
|
Time |
Topic |
Speaker |
Moderator |
|
17:00-17:20 |
Is BPH treatment a patient's choice or doctor's preference? |
Tan Yung Kha |
許毓昭 |
|
17:20-17:40 |
The role of ARPIs in early stage prostate cancer |
Axel Merseburger |
馮思中 |
|
17:40-17:50 |
Closing remarks |
馮思中 |
|
| 林口長庚紀念醫院 Linkou Chang Gung Memorial Hospital | ||||||||||
| 長庚國際會議中心 Chang Gung International Convention Center | 研究大樓 Research Building | 非 討 論 式 海 報 |
||||||||
| TIME | 3F 國際會議廳 (300人) |
2F 簡報室 (80人) |
2F 討論室A (50人) |
2F 討論室B (50人) |
2F 討論室D (50人) |
會議廳 A (142人) |
會議廳 C (142人) |
會議室1 (50人) |
會議室2 (50人) |
|
| 09:00-10:00 | 09:00-11:10 TUA State-of-the-Art Lectures |
TUA Symposium A Prostate Disease Management |
Industrial Session 1 | Moderated Poster 01 |
Podium 01 | 09:00-10:20 Meet the Experts 1 Difficult but Important Robot Surgery |
ISTUA | TUA Symposium B Prostate Cancer Precision Treatment |
||
| 10:00-10:30 | Break | Break | ||||||||
| 10:30-11:30 | Meet the Experts 2 Advanced Innovation in GU Stone Surgery |
Industrial Session 2 | Moderated Poster 02 |
Podium 02 | TUA Symposium C Renal Cell Carcinoma |
特色議程 1 法律 |
||||
| CO2 Vaginal Laser and SUI Treatment | ||||||||||
| 妮傲絲翠 | ||||||||||
| 11:30-12:00 | TUA General Assembly【3F 國際會議廳】 | |||||||||
| 12:00-13:00 | Lunch Symposium 1 | Lunch Symposium 2 | Lunch Symposium 3 | Lunch Symposium 4 | Lunch Symposium 5 | Lunch Symposium 6 | Lunch Symposium 7 | Lunch Symposium 8 | 12:00-15:30 理監事選舉 |
|
| Baxter 達文西智能連動床解決方案 | Highlight of APCCC 2024 | 間質性膀胱炎的流行病學、診斷及處方 | Maximizing treatment outcomes from choosing NHA | Meet the world expert in HIFU Treatment for Prostate cancer "what should we know in 2024" | Maximizing Treatment Outcomes for mCSPC Patients | New era of advanced GU cancers treatment | ||||
| 百特 | Novartis | BMS | Viatris | Astellas | 總達成 | J&J | Astrazeneca | |||
| 13:10-14:10 | 特色議程 2 健康管理大未來(政策面)/產官學研喜結合(實務觀) |
13:10-15:00 PPCS Symposium |
Industrial Session 3 | TUA Symposium D 預防勝於治療？ 疫苗的臨床效用 |
Podium 03 | 13:10-16:00 World Urology Forum |
ISTUA | 特色議程 3 年輕醫師講座 |
||
| 輸尿管狹窄治療的新選項 | ||||||||||
| 匯立 | ||||||||||
| 14:10-15:10 | Industrial Session 4 | TUA Symposium E 醫學資訊學: AI及大型語言模型LLM的應用及進展 |
Podium 04 | Workshop 1 從夢想到實踐 |
||||||
| 攝護腺健康指數phi交流研討會 | ||||||||||
| Beckman | ||||||||||
| 15:10-15:30 | Break | Break | ||||||||
| 15:30-16:30 | Senior Resident Debate 1 |
TUA Symposium F Female Bladder Outlet Obstruction |
Industrial Session 5 | Moderated Poster 03 |
特色議程 4 New Frontiers in GU 2024 |
TUA Symposium G 健保審查與爭議共識 |
理監事選舉 開票 |
|||
| Recent Advances in OAB | ||||||||||
| 久裕 | ||||||||||
| 16:30-17:30 | Senior Resident Debate 2 |
TUA Symposium H Interesting Stone Issues |
Industrial Session 6-1 Bone Metastasis and Bone-Targeting Agents 安進 |
Moderated Poster 04 |
TUA Symposium I Urothelial cancer |
特色議程 5 尿失禁及排尿手術障礙 |
||||
| Industrial Session 6-2 Complex Surgeries with Hugo™ RAS System 美敦力 |
||||||||||
| 18:15-21:00 | Gala Dinner 新莊典華 | |||||||||
| 林口長庚紀念醫院 Linkou Chang Gung Memorial Hospital | ||||||||||
| 長庚國際會議中心 Chang Gung International Convention Center | 研究大樓 Research Building | 非 討 論 式 海 報 |
||||||||
| TIME | 3F 國際會議廳 (300人) |
2F 簡報室 (80人) |
2F 討論室A (50人) |
2F 討論室B (50人) |
2F 討論室D (50人) |
會議廳 A (142人) |
會議廳 C (142人) |
會議室1 (50人) |
會議室2 (50人) |
|
| 09:30-10:30 | 特色議程 6 Sharing the Experience of Honorable Guests |
TUA Symposium J Complication after Kidney Transplantation |
TUA Symposium K 如何打造一個屬於自己的泌尿科診所 |
Moderated Poster 05 |
Podium 05 | TUA Symposium L Prostate Cancer |
TUA Symposium M Urinary Tract Infection in Children |
特色議程 7 兩性 |
Video Session | |
| 10:30-11:30 | TUA Symposium N Debate Crossfire辯論： 功能性泌尿學的選擇 |
TUA Symposium O PRP and Nutrition Issue in Andrology |
Workshop 2 軟式輸尿管鏡實作 |
Podium 06 | TUA Symposium P How to Optimize Post-RP BCR Care? |
TUA Symposium Q 健保核刪、申復、爭審與 申請共識 |
特色議程 8 倫理 |
Video Award | ||
| 11:30-11:50 | Break | |||||||||
| 11:50-13:00 | Lunch Symposium 9 | Lunch Symposium 10 | Lunch Symposium 11 | Lunch Symposium 12 | Lunch Symposium 13 | Lunch Symposium 14 | Lunch Symposium 15 | Lunch Symposium 16 | Lunch Symposium 17 | |
| Optimal Treatment Strategies for PC and BPH | Water Vapor Therapy for BPH | What can we leverage more with Da Vinci Robotic System? 達文西手術新術式探討 |
Can ED drugs really help your life? | Focal Therapy trend in the US：Treated with Focal One platform | Meet the Expert: Maximizing nmCRPC Treatment Outcomes by Choosing NHTs | The Future of ADCs in Treating Frontline LA/mUC | The Advancement of Cabozantinib-based Regimen in GU Cancers | Advancing Treatment Paradigm in mPC | ||
| Synmosa | Boston Scientific | Intuitive | 美時 | 捷元 | Jassen | Astellas | IPSEN | Bayer | ||
| 13:10-14:10 | 特色議程 9 研究之路甘苦談 |
特色議程 10 泌尿微創手術 |
Podium 07 | Nursing | 泌尿腫瘤委員會議 | |||||
| 13:30-14:30 Guideline Contest |
||||||||||
| 14:10-15:10 | 特色議程 11 大空戰時代-醫師的 個人品牌經營之道 |
|||||||||
| 15:30-18:00 | 研究大樓 會議室1 理監事會 | |||||||||